Peter Glassman, MBBS, MSc

Veterans Health Administration
Los Angeles, United States

Disclosure information not submitted.

Presentation(s):

• Use of Target Trial Emulation for VHA Drug Safety Evaluations: A Case Study with Bivalent COVID-19 Vaccination and Hospitalizations for Ischemic Stroke

  Monday, August 26, 2024
  5:45 PM – 6:00 PM CEST

• A Self-Controlled Case Series to Evaluate Risk of Ischemic Stroke Following Bivalent COVID-19 Vaccine Administration in a US Veteran Population

  Monday, August 26, 2024
  6:15 PM – 6:30 PM CEST